Closed
SectorHealthcare
9.66 -0.82
24h
Min
9.55
Max
9.76
Income | -173K -24M |
|---|---|
Sales | 302K 3.1M |
Profit margin | -795.026 |
Employees | 102 |
EBITDA | -303K -23M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +261.96% upside |
Next Earnings | 12 lis 2025 |
|---|
Market Cap | 22M 52M |
|---|---|
Previous open | 10.48 |
Previous close | 9.66 |
By Acuity
50%
50%
147 / 371 Ranking in Healthcare
By Trading Central
Confidence
Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 35.4 USD 261.96%
High 50 USD
Low 17 USD
Based on 7 Wall Street analysts offering 12 month price targets forMersana Therapeutics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$